22 §2698-A. Marketing costs (REPEALED)
§2698-A. Marketing costs (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 688, §C8 (AMD). PL 2005, c. 286, §§1,2 (AMD). PL 2011, c. 461, §3 (RP).
22 §2698-B. Actual price disclosure and certification (REPEALED)
§2698-B. Actual price disclosure and certification (REPEALED) SECTION HISTORY PL 2003, c. 667, §1 (NEW). PL 2003, c. 667, §2 (AFF). PL 2005, c. 402, §§1-4 (AMD). PL 2011, c. 461, §4 (RP).
22 §2699. Prescription drug practices (REPEALED)
§2699. Prescription drug practices (REPEALED) SECTION HISTORY RR 2003, c. 1, §17 (RAL). RR 2003, c. 1, §18 (AFF). PL 2003, c. 430, §1 (NEW). PL 2003, c. 430, §3 (AFF). PL 2003, c. 456, §1 (NEW). PL 2003, c. 673, §§FFF1,2 (AMD). PL 2003, c. 688, §§C9,10 (AMD). PL 2003, c. 688, §C11 (AFF). […]
22 §2700. Unused Pharmaceutical Disposal Program
§2700. Unused Pharmaceutical Disposal Program 1. Establishment; purpose. There is established the Unused Pharmaceutical Disposal Program, referred to in this chapter as “the program.” The purpose of the program is to ensure the safe, effective and proper disposal of unused pharmaceuticals. For purposes of compliance with federal law and regulation, the return of pharmaceuticals under […]
22 §2700-A. Prohibitions
§2700-A. Prohibitions 1. Definitions. As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings. A. [PL 2011, c. 461, §5 (RP).] B. “Manufacturer of prescription drugs” or “manufacturer” means a manufacturer of prescription drugs or biological products or an affiliate of the manufacturer or a labeler that […]
22 §2681. Maine Rx Plus Program established
§2681. Maine Rx Plus Program established The Maine Rx Plus Program, referred to in this subchapter as the “program,” is established to reduce prescription drug prices and to improve the quality of health care for residents of the State. The program is administered by the department and must utilize manufacturer rebates and pharmacy discounts to […]
22 §2682. Display of Maine Rx Plus Program participation information
§2682. Display of Maine Rx Plus Program participation information A drug dispensed pursuant to prescription, including a drug dispensed without charge to the consumer, must be accompanied by program participation information in a manner approved by the commissioner and as permitted by law. [PL 2001, c. 471, Pt. E, §5 (AMD); PL 2001, c. […]
22 §2685. Prescription drug academic detailing program
§2685. Prescription drug academic detailing program By January 1, 2008, the department shall establish a prescription drug academic detailing program, referred to in this section as “the program,” to enhance the health of residents of the State, to improve the quality of decisions regarding drug prescribing, to encourage better communication between the department and health […]
22 §2687. Maximum allowable cost list
§2687. Maximum allowable cost list 1. Comment period. The Department of Health and Human Services, office of MaineCare services shall establish a 17-day written comment period on any proposed change to the state maximum allowable cost list if the change results in a reduction in payment to pharmacies. The written comment period must be held […]
22 §2691. Short title; purpose
§2691. Short title; purpose This subchapter may be known and cited as the “Prescription Drug Price Reduction Act.” The Legislature finds that affordability is critical in providing access to prescription drugs for Maine residents. This subchapter is enacted by the Legislature as a positive measure to make prescription drugs more affordable for qualified Maine residents, […]